<i>KRAS</i> Variants Are Associated With Survival Outcomes and Genomic Alterations in Biliary Tract Cancers

The adverse impact of <i>KRAS</i> mutations in BTC is driven by G12 alterations in patients with IHC regardless of resection status, which was not observed in GB or EHC. There are unique comutational partners in distinct BTC subsets. These differences have important clinical implications in the era of KRAS-targeted therapeutics.

Authors

Institutions

Publication Details

Journal
JCO Precision Oncology
Published
2024-12-01
DOI
https://doi.org/10.1200/po.24.00263
Citations
3
Primary Topic
Cholangiocarcinoma and Gallbladder Cancer Studies
Type
article
Field-Weighted Citation Impact
1.72

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

KRAS Variants Are Associated With Survival Outcomes and Genomic Alterations in Biliary Tract Cancers

Alice C. Wei, Michael I. D’Angelica, Rebecca G. Gelfer, Hannah L. Kalvin et al.
3 citations
JCO Precision Oncology
Cholangiocarcinoma and Gallbladder Cancer Studies
1.72
article

KRAS Variants Are Associated With Survival Outcomes and Genomic Alterations in Biliary Tract Cancers

Alice C. Wei, Michael I. D’Angelica, Rebecca G. Gelfer, Hannah L. Kalvin, Wungki Park, Rohit Chandwani, William R. Jarnagin, Mithat Gönen, Kevin C. Soares, Vinod P. Balachandran, James J. Harding, T. Peter Kingham, Aistė Gulla, Eileen Mary O'Reilly, Jeffrey A. Drebin, Ghassan K. Abou‐Alfa, Yi Song
article en
3 citations

Abstract

The adverse impact of <i>KRAS</i> mutations in BTC is driven by G12 alterations in patients with IHC regardless of resection status, which was not observed in GB or EHC. There are unique comutational partners in distinct BTC subsets. These differences have important clinical implications in the era of KRAS-targeted therapeutics.

JCO Precision OncologyVol. 8(8)
Memorial Sloan Kettering Cancer Center (US), Vilnius University (LT), Trinity College Dublin (IE), Cornell University (US), Weill Cornell Medicine (US)
Memorial Sloan-Kettering Cancer Center, National Institutes of Health
Good health and well-being
Openalex Percentile: Top 14%
Cholangiocarcinoma and Gallbladder Cancer Studies
1.72
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.